Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Tytuł pozycji:

DNA Methylation Signatures and the Contribution of Age-Associated Methylomic Drift to Carcinogenesis in Early-Onset Colorectal Cancer.

Tytuł:
DNA Methylation Signatures and the Contribution of Age-Associated Methylomic Drift to Carcinogenesis in Early-Onset Colorectal Cancer.
Autorzy:
Joo JE; Colorectal Oncogenomics Group, Department of Clinical Pathology, The University of Melbourne, Parkville, Melbourne 3010, Australia.; University of Melbourne Centre for Cancer Research, Victorian Comprehensive Cancer Centre, Parkville, Melbourne 3000, Australia.
Clendenning M; Colorectal Oncogenomics Group, Department of Clinical Pathology, The University of Melbourne, Parkville, Melbourne 3010, Australia.; University of Melbourne Centre for Cancer Research, Victorian Comprehensive Cancer Centre, Parkville, Melbourne 3000, Australia.
Wong EM; Precision Medicine, Monash Health, Monash University, Clayton, Melbourne 3800, Australia.
Rosty C; Colorectal Oncogenomics Group, Department of Clinical Pathology, The University of Melbourne, Parkville, Melbourne 3010, Australia.; University of Melbourne Centre for Cancer Research, Victorian Comprehensive Cancer Centre, Parkville, Melbourne 3000, Australia.; School of Medicine, University of Queensland, Herston, Brisbane 4006, Australia.; Envoi Pathology, Brisbane 4059, Australia.
Mahmood K; Colorectal Oncogenomics Group, Department of Clinical Pathology, The University of Melbourne, Parkville, Melbourne 3010, Australia.; University of Melbourne Centre for Cancer Research, Victorian Comprehensive Cancer Centre, Parkville, Melbourne 3000, Australia.; Melbourne Bioinformatics, The University of Melbourne, Parkville, Melbourne 3010, Australia.
Georgeson P; Colorectal Oncogenomics Group, Department of Clinical Pathology, The University of Melbourne, Parkville, Melbourne 3010, Australia.; University of Melbourne Centre for Cancer Research, Victorian Comprehensive Cancer Centre, Parkville, Melbourne 3000, Australia.
Winship IM; Department of Medicine, The Royal Melbourne Hospital, University of Melbourne, Parkville, Melbourne 3050, Australia.; Genomic Medicine and Family Cancer Clinic, Royal Melbourne Hospital, Parkville, Melbourne 3050, Australia.
Preston SG; Colorectal Oncogenomics Group, Department of Clinical Pathology, The University of Melbourne, Parkville, Melbourne 3010, Australia.; University of Melbourne Centre for Cancer Research, Victorian Comprehensive Cancer Centre, Parkville, Melbourne 3000, Australia.
Win AK; Centre for Epidemiology and Biostatistics, The University of Melbourne, Melbourne 3010, Australia.
Dugué PA; Precision Medicine, Monash Health, Monash University, Clayton, Melbourne 3800, Australia.; Centre for Epidemiology and Biostatistics, The University of Melbourne, Melbourne 3010, Australia.; Cancer Epidemiology Division, Cancer Council Victoria, Melbourne 3004, Australia.
Jayasekara H; Colorectal Oncogenomics Group, Department of Clinical Pathology, The University of Melbourne, Parkville, Melbourne 3010, Australia.; University of Melbourne Centre for Cancer Research, Victorian Comprehensive Cancer Centre, Parkville, Melbourne 3000, Australia.; Cancer Epidemiology Division, Cancer Council Victoria, Melbourne 3004, Australia.
English D; Centre for Epidemiology and Biostatistics, The University of Melbourne, Melbourne 3010, Australia.; Cancer Epidemiology Division, Cancer Council Victoria, Melbourne 3004, Australia.
Macrae FA; Department of Medicine, The Royal Melbourne Hospital, University of Melbourne, Parkville, Melbourne 3050, Australia.; Genomic Medicine and Family Cancer Clinic, Royal Melbourne Hospital, Parkville, Melbourne 3050, Australia.; Colorectal Medicine and Genetics, The Royal Melbourne Hospital, Parkville, Melbourne 3050, Australia.
Hopper JL; Centre for Epidemiology and Biostatistics, The University of Melbourne, Melbourne 3010, Australia.
Jenkins MA; Centre for Epidemiology and Biostatistics, The University of Melbourne, Melbourne 3010, Australia.
Milne RL; Precision Medicine, Monash Health, Monash University, Clayton, Melbourne 3800, Australia.; Centre for Epidemiology and Biostatistics, The University of Melbourne, Melbourne 3010, Australia.; Cancer Epidemiology Division, Cancer Council Victoria, Melbourne 3004, Australia.
Giles GG; Precision Medicine, Monash Health, Monash University, Clayton, Melbourne 3800, Australia.; Centre for Epidemiology and Biostatistics, The University of Melbourne, Melbourne 3010, Australia.; Cancer Epidemiology Division, Cancer Council Victoria, Melbourne 3004, Australia.
Southey MC; Precision Medicine, Monash Health, Monash University, Clayton, Melbourne 3800, Australia.; Cancer Epidemiology Division, Cancer Council Victoria, Melbourne 3004, Australia.; Department of Clinical Pathology, The University of Melbourne, Parkville, Melbourne 3010, Australia.
Buchanan DD; Colorectal Oncogenomics Group, Department of Clinical Pathology, The University of Melbourne, Parkville, Melbourne 3010, Australia.; University of Melbourne Centre for Cancer Research, Victorian Comprehensive Cancer Centre, Parkville, Melbourne 3000, Australia.; Genomic Medicine and Family Cancer Clinic, Royal Melbourne Hospital, Parkville, Melbourne 3050, Australia.
Źródło:
Cancers [Cancers (Basel)] 2021 May 25; Vol. 13 (11). Date of Electronic Publication: 2021 May 25.
Typ publikacji:
Journal Article
Język:
English
Imprint Name(s):
Original Publication: Basel, Switzerland : MDPI
References:
Cancer Res. 1998 Dec 1;58(23):5489-94. (PMID: 9850084)
Aging (Albany NY). 2018 Apr 18;10(4):573-591. (PMID: 29676998)
Epigenetics Chromatin. 2015 Jan 27;8:6. (PMID: 25972926)
Gastroenterol Rep (Oxf). 2014 Feb;2(1):16-20. (PMID: 24760232)
Cancer Res. 2020 Feb 1;80(3):367-374. (PMID: 31694907)
Int J Obes (Lond). 2019 Jan;43(1):176-188. (PMID: 29717273)
Nucleic Acids Res. 2013 Apr;41(7):e90. (PMID: 23476028)
J Gastroenterol Hepatol. 2015 Jan;30(1):6-13. (PMID: 25251195)
Nat Genet. 2018 Apr;50(4):591-602. (PMID: 29610480)
BMC Res Notes. 2015 Oct 06;8:543. (PMID: 26438025)
Bioinformatics. 2012 Mar 15;28(6):882-3. (PMID: 22257669)
Science. 2015 Jan 2;347(6217):78-81. (PMID: 25554788)
Carcinogenesis. 2010 Jun;31(6):1158-63. (PMID: 20395289)
Nucleic Acids Res. 2016 Feb 18;44(3):e20. (PMID: 26384415)
Nat Rev Genet. 2018 Jun;19(6):371-384. (PMID: 29643443)
Cold Spring Harb Perspect Biol. 2016 Sep 01;8(9):. (PMID: 27194046)
J Clin Invest. 2014 Jan;124(1):24-9. (PMID: 24382386)
Bioinformatics. 2014 May 15;30(10):1363-9. (PMID: 24478339)
J Natl Cancer Inst. 2018 Jul 1;110(7):791-793. (PMID: 29370418)
Genome Med. 2020 Jun 24;12(1):56. (PMID: 32580750)
Nat Methods. 2018 Dec;15(12):1059-1066. (PMID: 30504870)
Cancer Res. 2019 Feb 1;79(3):495-504. (PMID: 30291105)
Clin Epigenetics. 2018 Oct 16;10(1):123. (PMID: 30326963)
Genome Biol. 2016 Oct 3;17(1):205. (PMID: 27716309)
Gut. 2018 Nov;67(11):1995-2005. (PMID: 28982739)
Mol Cell. 2013 Jan 24;49(2):359-367. (PMID: 23177740)
J Gastroenterol Hepatol. 2017 Feb;32(2):427-438. (PMID: 27273229)
Nucleic Acids Res. 2015 Apr 20;43(7):e47. (PMID: 25605792)
Clin Epigenetics. 2015 Feb 20;7:12. (PMID: 25806089)
Cancer Causes Control. 2013 Feb;24(2):335-41. (PMID: 23224326)
Gastroenterology. 2018 Mar;154(4):897-905.e1. (PMID: 29146522)
Genome Res. 2010 Mar;20(3):332-40. (PMID: 20107151)
PLoS One. 2012;7(9):e45357. (PMID: 23049789)
Epigenetics. 2013 Jul;8(7):748-55. (PMID: 23804018)
BMC Bioinformatics. 2010 Nov 30;11:587. (PMID: 21118553)
Lancet. 2014 Apr 26;383(9927):1490-1502. (PMID: 24225001)
Int J Epidemiol. 2018 Apr 1;47(2):387-388i. (PMID: 29490034)
Cancer Cell Int. 2017 Aug 7;17:75. (PMID: 28794688)
Oncogene. 2018 Feb 1;37(5):566-577. (PMID: 28991233)
Mayo Clin Proc. 2014 Feb;89(2):216-24. (PMID: 24393412)
Bioinformatics. 2016 Jan 15;32(2):286-8. (PMID: 26424855)
J Pediatr Endocrinol Metab. 2015 Mar;28(3-4):251-63. (PMID: 25581748)
Nucleic Acids Res. 2016 May 5;44(8):e71. (PMID: 26704973)
Clin Epigenetics. 2020 Jan 3;12(1):5. (PMID: 31900199)
Genome Biol. 2014 Dec 03;15(12):503. (PMID: 25599564)
JAMA Oncol. 2017 Apr 1;3(4):464-471. (PMID: 27978560)
Cancer Epidemiol Biomarkers Prev. 2007 Nov;16(11):2331-43. (PMID: 17982118)
J Clin Pathol. 2001 Jul;54(7):533-8. (PMID: 11429425)
Int J Epidemiol. 2017 Dec 1;46(6):1757-1757i. (PMID: 28641380)
Genome Biol. 2013;14(10):R115. (PMID: 24138928)
J Natl Cancer Inst. 2014 Jun 28;106(7):. (PMID: 24973978)
Science. 2018 Mar 23;359(6382):1376-1383. (PMID: 29519916)
J Natl Cancer Inst. 2005 Sep 21;97(18):1330-8. (PMID: 16174854)
Clin Gastroenterol Hepatol. 2020 Nov;18(12):2752-2759.e2. (PMID: 31622737)
Am J Gastroenterol. 2011 Nov;106(11):1911-21; quiz 1922. (PMID: 21912438)
Cancer Res. 2014 Mar 1;74(5):1475-83. (PMID: 24453003)
PLoS One. 2014 Oct 06;9(10):e108668. (PMID: 25286412)
Br J Cancer. 2018 Oct;119(7):785-792. (PMID: 30287914)
Breast Cancer Res Treat. 2016 Nov;160(1):173-180. (PMID: 27604360)
Am J Surg Pathol. 2013 Mar;37(3):399-405. (PMID: 23348208)
Grant Information:
U01 CA167551 United States CA NCI NIH HHS
Contributed Indexing:
Keywords: DNA methylation; age acceleration; colorectal cancer; early onset colorectal cancer; epigenetic drift
Entry Date(s):
Date Created: 20210602 Latest Revision: 20220114
Update Code:
20240104
PubMed Central ID:
PMC8199056
DOI:
10.3390/cancers13112589
PMID:
34070516
Czasopismo naukowe
We investigated aberrant DNA methylation (DNAm) changes and the contribution of ageing-associated methylomic drift and age acceleration to early-onset colorectal cancer (EOCRC) carcinogenesis. Genome-wide DNAm profiling using the Infinium HM450K on 97 EOCRC tumour and 54 normal colonic mucosa samples was compared with: (1) intermediate-onset CRC (IOCRC; diagnosed between 50-70 years; 343 tumour and 35 normal); and (2) late-onset CRC (LOCRC; >70 years; 318 tumour and 40 normal). CpGs associated with age-related methylation drift were identified using a public dataset of 231 normal mucosa samples from people without CRC. DNAm-age was estimated using epiTOC2. Common to all three age-of-onset groups, 88,385 (20% of all CpGs) CpGs were differentially methylated between tumour and normal mucosa. We identified 234 differentially methylated genes that were unique to the EOCRC group; 13 of these DMRs/genes were replicated in EOCRC compared with LOCRCs from TCGA. In normal mucosa from people without CRC, we identified 28,154 CpGs that undergo ageing-related DNAm drift, and of those, 65% were aberrantly methylated in EOCRC tumours. Based on the mitotic-based DNAm clock epiTOC2, we identified age acceleration in normal mucosa of people with EOCRC compared with normal mucosa from the IOCRC, LOCRC groups ( p = 3.7 × 10 -16 ) and young people without CRC ( p = 5.8 × 10 -6 ). EOCRC acquires unique DNAm alterations at 234 loci. CpGs associated with ageing-associated drift were widely affected in EOCRC without needing the decades-long accrual of DNAm drift as commonly seen in intermediate- and late-onset CRCs. Accelerated ageing in normal mucosa from people with EOCRC potentially underlies the earlier age of diagnosis in CRC carcinogenesis.
Zaloguj się, aby uzyskać dostęp do pełnego tekstu.

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies